Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

72
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
72
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

64
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
64
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

63
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
63
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

36
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
36
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

42
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
42
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

71
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
71

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reported safety events from ultrasound enhancing agents: a critical reappraisal.

Echo research and practice·2026
Same author

Nurse-Led, Technology-Based Interventions to Improve Self-Care in Heart Failure Patients After Hospital Discharge: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

European journal of cardiovascular nursing·2026
Same author

Assessing Left Atrial Volume Indexation to Predict Mortality in Individuals With Overweight and Obesity.

Circulation. Cardiovascular imaging·2026
Same author

Decoding the TR Enigma: Cardiac Index Phenotypes, Congestion, and Prognosis.

Circulation. Cardiovascular imaging·2026
Same author

Using big data to search for possible geographic clustering of Congenital Heart Disease (CHD) across Australia.

PLOS digital health·2026
Same author

Increasing Left Ventricular Mass and Death in Men and Women Investigated With Echocardiography.

Journal of the American Heart Association·2025

Related Experiment Video

Updated: Oct 5, 2025

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

18.7K

Moderate aortic stenosis: culprit or bystander?

Varayini Pankayatselvan1, Inbar Raber2, David Playford3

  • 1Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

Open Heart
|January 25, 2022
PubMed
Summary

Untreated moderate aortic stenosis (AS) poses significant mortality risks. Emerging data suggests aortic valve replacement (AVR) may be beneficial, challenging traditional views on managing this common valvular disease.

Keywords:
echocardiographyepidemiologytranscatheter aortic valve replacement

More Related Videos

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.8K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.5K

Related Experiment Videos

Last Updated: Oct 5, 2025

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

18.7K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.8K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.5K

Area of Science:

  • Cardiology
  • Valvular Heart Disease
  • Cardiac Surgery

Background:

  • Non-rheumatic aortic stenosis (AS) is a prevalent valvular heart disease in developed nations.
  • Severe symptomatic AS guidelines recommend aortic valve replacement (AVR), but moderate AS management remains debated.
  • Historically, moderate AS was considered benign, with AVR risks outweighing benefits.

Purpose of the Study:

  • To review contemporary data on morbidity and mortality in moderate AS.
  • To evaluate the evolving risk/benefit paradigm for AVR in moderate AS.
  • To discuss current understanding, guidelines, and future directions for moderate AS management.

Main Methods:

  • Literature review of current epidemiological data.
  • Analysis of clinical outcomes and mortality risks associated with moderate AS.
  • Appraisal of evolving guidelines and periprocedural/perioperative outcomes for AVR.

Main Results:

  • Emerging data indicates substantial mortality risk in untreated moderate AS.
  • Improvements in AVR periprocedural and perioperative mortality have been observed.
  • Traditional risk/benefit assessments for moderate AS intervention are being challenged.

Conclusions:

  • Contemporary data necessitates re-evaluation of moderate AS management strategies.
  • The timing of AVR in moderate AS requires careful consideration based on updated evidence.
  • Further studies are needed to refine surveillance and intervention thresholds for moderate AS.